Complete Filing Data
MiNK Therapeutics, Inc. reported Stockholders Equity of -$14.23 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean MiNK Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$12.5M | -$10.8M | -$22.5M | -$28.0M | -$30.2M | -$16.2M |
| Other Comprehensive Income Loss Net Of Tax | -$87.3K | -$200.6K | -$138.5K | $332.8K | $897.8K | -$1.4M |
| Research And Development Expense | $5.8M | $6.3M | $15.5M | $23.1M | $14.0M | $9.5M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$87.3K | -$200.6K | -$138.5K | $332.8K | $897.8K | -$1.4M |
| Operating Income Loss | -$12.6M | -$11.3M | -$22.9M | -$30.9M | -$28.4M | -$14.6M |
| General And Administrative Expense | $6.7M | $4.3M | $7.4M | $7.8M | $4.6M | $1.3M |
| Comprehensive Income Net Of Tax | -$12.6M | -$11.0M | -$22.6M | -$27.7M | -$29.3M | -$17.6M |
| Interest Income Expense Net | $180.2K | $172.6K | $463.3K | $253.3K | -$2.4M | |
| Other Nonoperating Income Expense | -$32.4K | $330.9K | -$10.00 | $2.7M | $221.9K | $839.2K |
| Interest Expense | $2.4M | $2.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$2.9M | -$4.2M | -$2.8M | -$1.8M | -$2.7M | -$3.8M | -$5.1M | -$6.2M | -$5.7M | -$6.3M | -$6.1M | -$7.8M | -$14.3M | -$6.3M | -$3.8M | -$6.0M | -$4.3M | -$4.4M |
| Other Comprehensive Income Loss Net Of Tax | $27.2K | -$56.9K | -$30.9K | -$61.5K | -$225.6K | $45.2K | $88.6K | -$28.0K | -$81.3K | -$1.4M | $1.4M | $522.8K | $546.1K | -$165.7K | $353.3K | -$803.5K | -$185.6K | $635.9K |
| Research And Development Expense | $1.1M | $1.8M | $1.3M | $540.6K | $1.8M | $2.5M | $3.4M | $4.6M | $4.2M | $6.1M | $5.9M | $5.3M | $3.3M | $3.6M | $3.1M | $2.5M | ||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $27.2K | -$56.9K | -$30.9K | -$61.5K | -$225.6K | $45.2K | $88.6K | -$28.0K | -$81.3K | -$1.4M | $1.4M | $522.8K | $546.1K | -$165.7K | $353.3K | -$803.5K | ||
| Operating Income Loss | -$3.2M | -$4.1M | -$2.7M | -$1.9M | -$3.1M | -$3.8M | -$5.2M | -$6.3M | -$5.9M | -$8.0M | -$7.7M | -$7.4M | -$13.4M | -$5.6M | -$3.0M | -$5.9M | ||
| General And Administrative Expense | $1.8M | $1.8M | $1.3M | $1.2M | $1.1M | $1.3M | $1.8M | $1.8M | $1.7M | $1.8M | $1.8M | $2.1M | $814.9K | $867.9K | $595.0K | $466.9K | ||
| Comprehensive Income Net Of Tax | -$2.9M | -$4.3M | -$2.8M | -$1.9M | -$2.9M | -$3.8M | -$5.0M | -$6.2M | -$5.8M | -$7.7M | -$4.7M | -$7.3M | -$13.7M | -$6.5M | -$3.5M | -$6.8M | ||
| Interest Income Expense Net | $55.2K | $348.00 | $13.5K | $78.0K | $38.4K | $16.6K | $107.3K | $146.4K | $168.1K | $93.0K | $26.4K | -$848.00 | -$881.3K | -$805.0K | ||||
| Other Nonoperating Income Expense | $240.7K | -$185.7K | -$79.5K | $330.9K | $8.00 | $1.6M | $1.6M | -$402.0K | -$364.8K | $82.3K | -$94.2K | $519.9K | ||||||
| Interest Expense | $848.00 | $881.3K | $743.7K | $639.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$14.2M | -$19.6M | -$18.1M | -$401.3K | $23.8M | -$53.9M | -$36.3M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $13.4M | $4.6M | $3.4M | $19.6M | $38.9M | $2.7M | $299.0K |
| Retained Earnings Accumulated Deficit | -$156.7M | -$144.2M | -$133.4M | -$110.9M | -$82.9M | -$52.7M | |
| Property Plant And Equipment Net | $390.9K | $732.9K | $954.0K | $1.1M | $606.6K | $458.4K | |
| Other Liabilities Current | $2.8M | $2.4M | $2.5M | $2.6M | $5.8M | $5.7M | |
| Other Assets Current | $211.2K | $164.2K | $178.0K | $470.3K | $744.3K | $913.6K | |
| Liabilities Current | $13.0M | $7.0M | $11.4M | $12.7M | $16.5M | $14.2M | |
| Liabilities And Stockholders Equity | $14.2M | $5.7M | $4.6M | $21.5M | $40.2M | $4.6M | |
| Common Stock Value | $48.00 | $40.00 | $35.00 | $339.00 | $335.00 | $242.00 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $8.8M | $1.2M | -$16.3M | -$19.3M | $36.2M | $2.4M | |
| Assets Current | $13.8M | $5.0M | $3.6M | $20.4M | $39.6M | $4.1M | |
| Assets | $14.2M | $5.7M | $4.6M | $21.5M | $40.2M | $4.6M | |
| Additional Paid In Capital Common Stock | $143.2M | $125.2M | $115.8M | $110.8M | $107.3M | $383.7K | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$718.9K | -$631.6K | -$430.9K | -$292.5K | -$625.3K | -$1.5M | |
| Accrued Liabilities Current | $1.6M | $1.9M | $5.0M | $4.2M | $1.8M | $1.9M | |
| Accounts Payable Current | $3.4M | $2.7M | $3.9M | $5.8M | $3.0M | $3.1M | |
| Cash And Cash Equivalents At Carrying Value | $13.4M | $4.6M | $3.4M | $19.6M | $38.9M | ||
| Other Liabilities Noncurrent | $0.00 | $48.1K | $108.5K | $383.1K | |||
| Treasury Stock Retired Cost Method Amount | $477.6K | $157.2K | |||||
| Gain On Forgiveness Of Liability | $1.8M | $266.8K | $2.8M | ||||
| Interest Accrued On Related Party Note | $100.0K | $79.4K | |||||
| Purchases Of Plant And Equipment In Accounts Payable And Accrued Liabilities | |||||||
| Interest Accrued On Convertible Affiliated Note | $2.4M | $2.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$13.5M | -$25.2M | -$21.8M | -$17.6M | -$16.6M | -$20.3M | -$13.6M | -$9.5M | -$4.5M | $6.8M | $13.7M | $17.3M | -$76.5M | -$63.2M | -$57.1M | -$51.3M | -$44.5M | -$40.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $14.3M | $1.7M | $3.2M | $6.3M | $9.3M | $5.8M | $6.4M | $10.6M | $14.9M | $24.2M | $29.8M | $34.7M | $819.5K | $1.7M | $810.3K | $1.3M | ||
| Retained Earnings Accumulated Deficit | -$154.1M | -$151.2M | -$146.9M | -$141.7M | -$139.9M | -$137.2M | -$127.9M | -$122.8M | -$116.6M | -$103.2M | -$96.8M | -$90.7M | -$77.2M | |||||
| Property Plant And Equipment Net | $429.3K | $473.2K | $687.5K | $799.5K | $850.0K | $895.0K | $991.5K | $1.1M | $1.1M | $803.1K | $787.5K | $665.2K | $635.9K | |||||
| Other Liabilities Current | $2.8M | $2.5M | $2.4M | $2.4M | $2.3M | $2.3M | $2.3M | $2.3M | $2.5M | $2.1M | $2.2M | $5.4M | $5.4M | |||||
| Other Assets Current | $32.00 | $55.2K | $108.7K | $11.2K | $61.1K | $122.5K | $29.3K | $166.0K | $320.9K | $37.5K | $378.1K | $604.6K | $2.6M | |||||
| Liabilities Current | $13.4M | $13.2M | $12.1M | $7.4M | $10.1M | $11.1M | $10.4M | $11.5M | $11.2M | $18.4M | $17.4M | $18.8M | $80.6M | |||||
| Liabilities And Stockholders Equity | $15.0M | $2.5M | $4.3M | $7.4M | $10.3M | $6.9M | $7.5M | $12.1M | $16.6M | $25.3M | $31.1M | $36.1M | $4.1M | |||||
| Common Stock Value | $46.00 | $40.00 | $40.00 | $395.00 | $394.00 | $347.00 | $345.00 | $345.00 | $343.00 | $338.00 | $337.00 | $336.00 | $242.00 | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$1.3M | $2.4M | -$4.7M | -$4.2M | -$1.9M | |||||||||||||
| Assets Current | $14.5M | $2.0M | $3.6M | $6.6M | $9.5M | $6.0M | $6.5M | $11.1M | $15.5M | $24.5M | $30.3M | $35.5M | $3.4M | |||||
| Assets | $15.0M | $2.5M | $4.3M | $7.4M | $10.3M | $6.9M | $7.5M | $12.1M | $16.6M | $25.3M | $31.1M | $36.1M | $4.1M | |||||
| Additional Paid In Capital Common Stock | $141.3M | $126.7M | $125.8M | $124.8M | $123.9M | $117.3M | $114.7M | $113.7M | $112.5M | $110.0M | $109.2M | $108.1M | $1.5M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$692.1K | -$719.3K | -$662.4K | -$672.8K | -$611.4K | -$385.8K | -$313.2K | -$401.8K | -$373.8K | -$78.3K | $1.3M | -$102.5K | -$789.3K | |||||
| Accrued Liabilities Current | $1.3M | $1.9M | $2.0M | $2.6M | $4.6M | $5.3M | $3.8M | $4.2M | $2.8M | $2.8M | $2.8M | $2.7M | $3.1M | |||||
| Accounts Payable Current | $3.7M | $3.3M | $2.7M | $2.4M | $3.2M | $3.5M | $4.3M | $4.9M | $6.0M | $5.2M | $4.8M | $3.7M | $1.6M | |||||
| Cash And Cash Equivalents At Carrying Value | $14.3M | $1.7M | $3.2M | $6.3M | $9.3M | $5.8M | $6.4M | $10.6M | $14.9M | $24.2M | $29.8M | $34.7M | ||||||
| Other Liabilities Noncurrent | $2.9K | $23.3K | $31.6K | $64.0K | $79.3K | $94.2K | $58.3K | $27.5K | ||||||||||
| Treasury Stock Retired Cost Method Amount | $97.7K | $379.9K | $157.2K | |||||||||||||||
| Gain On Forgiveness Of Liability | ||||||||||||||||||
| Interest Accrued On Related Party Note | $25.0K | $4.4K | ||||||||||||||||
| Purchases Of Plant And Equipment In Accounts Payable And Accrued Liabilities | $23.0K | $91.9K | ||||||||||||||||
| Interest Accrued On Convertible Affiliated Note | $743.7K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Grant And Recognition | $2.6M | $2.7M | $3.7M | $3.1M | $1.6M | $1.4K |
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $14.0K | $106.8K | $131.9K | $96.0K | $124.3K | $86.5K |
| Share Based Compensation | $2.7M | $1.8M | $3.9M | $3.0M | $1.7M | $87.8K |
| Net Cash Provided By Used In Operating Activities | -$5.9M | -$9.6M | -$15.8M | -$18.9M | -$12.8M | -$8.3M |
| Net Cash Provided By Used In Financing Activities | $14.7M | $10.8M | -$407.2K | -$155.6K | $49.3M | $11.1M |
| Increase Decrease In Prepaid Expense | $29.8K | $194.2K | -$245.6K | $296.9K | -$488.8K | $400.7K |
| Increase Decrease In Other Operating Capital Net | -$1.9M | -$2.2M | -$2.5M | -$3.0M | -$3.5M | -$465.0K |
| Increase Decrease In Accounts Payable | $689.7K | -$1.2M | -$1.9M | $2.7M | -$152.0K | $607.9K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$13.4K | -$54.7K | -$25.3K | $19.4K | $16.9K | -$281.2K |
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | $612.2K | $524.6K | $495.6K | $283.7K | $168.6K | $98.2K |
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | $720.2K | -$393.8K | $2.0M | $3.4M | ||
| Proceeds From Employee Stock Purchases And Option Exercises | $440.3K | $20.0K | $70.5K | $1.6K | ||
| Payments To Acquire Property Plant And Equipment | $73.6K | $250.0K | $249.0K | $95.2K | ||
| Net Cash Provided By Used In Investing Activities | -$73.6K | -$250.0K | -$249.0K | -$95.2K | ||
| Proceeds From Stock Options Exercised | $1.6K | $150.00 | $900.00 | |||
| Proceeds From Issuance Of Related Party Note | $5.0M | |||||
| Proceeds From Issuance Of Convertible Affiliated Note | $9.5M | $10.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Grant And Recognition | $620.6K | $888.5K | $563.2K | $857.8K | $818.9K | $697.6K | $906.2K | $864.9K | $887.8K | $745.9K | $796.9K | $741.8K | $365.8K | $356.1K | $263.1K | $347.00 | $244.00 | $400.00 |
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $8.1K | $5.9K | $25.5K | $25.3K | $27.0K | $33.1K | $33.3K | $33.3K | $27.0K | $3.9K | $43.7K | $21.6K | $51.2K | $19.9K | $10.4K | $12.6K | $29.5K | |
| Share Based Compensation | $591.1K | $592.0K | $921.1K | $785.5K | $283.0K | |||||||||||||
| Net Cash Provided By Used In Operating Activities | -$1.3M | -$2.5M | -$4.4M | -$4.2M | -$4.2M | |||||||||||||
| Net Cash Provided By Used In Financing Activities | $576.00 | $5.0M | -$334.4K | $689.00 | $2.3M | |||||||||||||
| Increase Decrease In Prepaid Expense | -$10.4K | $6.3K | $10.0K | $182.0K | $135.5K | |||||||||||||
| Increase Decrease In Other Operating Capital Net | -$548.1K | -$727.1K | -$758.4K | -$1.1M | $425.2K | |||||||||||||
| Increase Decrease In Accounts Payable | -$68.6K | -$424.4K | $153.9K | $642.2K | -$306.8K | |||||||||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$1.8K | -$14.8K | -$29.3K | -$4.6K | $42.8K | |||||||||||||
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | $573.6K | $530.6K | $578.5K | $476.7K | $409.0K | $545.1K | $432.5K | $385.6K | $332.6K | $232.8K | $213.6K | $193.2K | $147.0K | |||||
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | $101.2K | $324.5K | -$549.5K | $1.2M | $146.5K | |||||||||||||
| Proceeds From Employee Stock Purchases And Option Exercises | $576.00 | $6.9K | $45.5K | $689.00 | ||||||||||||||
| Payments To Acquire Property Plant And Equipment | $13.5K | $39.5K | ||||||||||||||||
| Net Cash Provided By Used In Investing Activities | -$13.5K | -$39.5K | ||||||||||||||||
| Proceeds From Stock Options Exercised | $689.00 | |||||||||||||||||
| Proceeds From Issuance Of Related Party Note | $5.0M | |||||||||||||||||
| Proceeds From Issuance Of Convertible Affiliated Note | $2.3M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$2.93 | -$2.86 | -$6.54 | -$0.83 | -$1.16 | -$0.67 |
| Weighted Average Number Of Shares Outstanding Basic | 4.3M | 3.8M | 3.4M | 33.7M | 26.0M | |
| Weighted Average Number Of Diluted Shares Outstanding | 4.3M | 3.8M | 3.4M | 33.7M | 26.0M | |
| Earnings Per Share Basic | $-2.93 | $-2.86 | $-6.54 | $-0.83 | $-1.16 | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Authorized | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 35.0M |
| Common Stock Shares Issued | 4.7M | 4.0M | 3.5M | 33.9M | 33.5M | 24.2M |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 26.0M | 24.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.65 | -$1.06 | -$0.70 | -$0.46 | -$0.73 | -$1.10 | -$0.15 | -$0.18 | -$0.17 | -$0.19 | -$0.18 | -$0.23 | -$0.59 | -$0.26 | -$0.16 | -$0.25 |
| Weighted Average Number Of Shares Outstanding Basic | 4.4M | 4.0M | 4.0M | 4.0M | 3.7M | 3.5M | 34.5M | 34.4M | 34.0M | 33.8M | 33.6M | 33.5M | 24.2M | 24.2M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 4.4M | 4.0M | 4.0M | 4.0M | 3.7M | 3.5M | 34.5M | 34.4M | 34.0M | 33.8M | 33.6M | 33.5M | 24.2M | 24.2M | ||
| Earnings Per Share Basic | $-0.65 | $-1.06 | $-0.70 | $-0.46 | $-0.73 | $-1.10 | $-0.15 | $-0.18 | $-0.17 | $-0.19 | $-0.18 | $-0.23 | $-0.59 | $-0.26 | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Authorized | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | ||||
| Common Stock Shares Issued | 4.6M | 4.0M | 4.0M | 39.5M | 39.4M | 34.7M | 34.5M | 34.5M | 34.3M | 33.8M | 33.7M | 33.6M | 24.2M | |||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 33.5M | 24.2M | 24.2M | 24.1M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Prepaid Expense Current | $276.4K | $246.6K | $53.1K | $298.7K | $1.8K | $492.1K |
| Depreciation | $181.7K | $215.4K | $204.6K | $121.7K | $78.0K | $55.1K |
| Stock Issued During Period Value Stock Options Exercised | $1.6K | $150.00 | $900.00 | |||
| Interest Paid Net | $9.5K | $13.1K | $27.5K | $10.8K | ||
| Stock Issued During Period Value Stock Options Exercised And Employee Stock Purchase Plan | $440.3K | $20.0K | $70.5K | |||
| Due To Related Party | $15.4M | $13.4M | $11.2M | $9.1M | ||
| Stock Issued During Period Value Employee Benefit Plan | $370.6K | $533.7K | $136.3K | |||
| Stock Issued During Period Shares Stock Options Exercised | 105.2K | 258.6K | 41.7K | |||
| Change In Fair Value Of Related Party Note | $154.8K | $638.0K | ||||
| Purchase Of Treasury Shares To Satisfy Tax Withholdings | 173.4K | 477.6K | 157.2K | |||
| Stock Issued During Period Shares Restricted Stock Award Gross | 36.1K | 30.2K | 17.5K | 60.6K | ||
| Change In Fair Value Of Convertible Affiliated Note | $9.8M | $3.8M | ||||
| Related Party Note | $4.9M | |||||
| Due To Related Parties Current | $5.9M | $3.5M | ||||
| Insurance Financing Agreement | $257.2K | $172.0K | $109.0K | $444.0K | $643.0K | |
| Stock Issued During Period Value Restricted Stock Award Forfeitures | $75.00 | $100.00 | ||||
| Stock Issued During Period Shares Employee Benefit Plan | 35.4K | 60.4K | 125.2K | |||
| Stock Issued1 | ||||||
| Issuance Of Stock Options For Payment Of Certain Employee Bonuses | $1.0M | |||||
| Issuance Of Related Party Note | $792.9K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prepaid Expense Current | $253.1K | $274.1K | $236.2K | $235.8K | $98.8K | $59.4K | $42.0K | $265.8K | $309.1K | $262.9K | $104.4K | $183.7K | $13.2K | |||||
| Depreciation | $50.8K | $53.8K | $45.7K | $27.1K | $16.2K | |||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $540.00 | $6.3K | $22.0K | $494.00 | $301.00 | $689.00 | $150.00 | $350.00 | $150.00 | $400.00 | ||||||||
| Interest Paid Net | $3.7K | $5.1K | $10.0K | $1.6K | ||||||||||||||
| Stock Issued During Period Value Stock Options Exercised And Employee Stock Purchase Plan | $408.2K | $6.8K | $6.9K | $3.0K | $45.5K | |||||||||||||
| Due To Related Party | $15.0M | $14.5M | $13.9M | $12.9M | $12.3M | $11.8M | $10.6M | $10.1M | ||||||||||
| Stock Issued During Period Value Employee Benefit Plan | $370.6K | $187.4K | $346.3K | $136.3K | ||||||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 15.5K | 61.8K | 84.4K | |||||||||||||||
| Change In Fair Value Of Related Party Note | $193.9K | $364.1K | $167.9K | $180.9K | $169.4K | |||||||||||||
| Purchase Of Treasury Shares To Satisfy Tax Withholdings | 379.9K | |||||||||||||||||
| Stock Issued During Period Shares Restricted Stock Award Gross | 77.1K | 30.4K | ||||||||||||||||
| Change In Fair Value Of Convertible Affiliated Note | $9.2M | $1.2M | -$684.4K | $3.0M | ||||||||||||||
| Related Party Note | $0.00 | $0.00 | $0.00 | $4.6M | $4.4M | $4.2M | ||||||||||||
| Due To Related Parties Current | $8.4M | $7.6M | $7.0M | $5.0M | ||||||||||||||
| Insurance Financing Agreement | ||||||||||||||||||
| Stock Issued During Period Value Restricted Stock Award Forfeitures | $75.00 | |||||||||||||||||
| Stock Issued During Period Shares Employee Benefit Plan | 476.8K | |||||||||||||||||
| Stock Issued1 | $726.3K | |||||||||||||||||
| Issuance Of Stock Options For Payment Of Certain Employee Bonuses | $132.6K | |||||||||||||||||
| Issuance Of Related Party Note | $792.9K |
Most recent annual filing with the SEC: March 31, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.